Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Diabetologia
|
October 30, 1998
Ingested interferon alpha suppresses type I diabetes in non-obese diabetic mice
S A Brod, M Malone, S Darcan, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
February 1, 1995
Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons
S A Brod, M Scott, D K Burns, et al.
The International Journal of Neuroscience
|
June 1, 1997
IFN-beta 1b treatment of relapsing multiple sclerosis has no effect on CD3-induced inflammatory or counterregulatory anti-inflammatory cytokine secretion ex vivo after nine months
S A Brod, L D Nelson, M Khan, et al.
Journal of the Neurological Sciences
|
March 13, 2012
Variable results after rituximab in neuromyelitis optica
J W Lindsey, K M Meulmester, S A Brod, et al.
Autoimmunity
|
January 1, 1996
Oral administration of type I interferon modulates the course of experimental allergic neuritis
F J Vriesendorp, R E Flynn, M Khan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 4, 2000
Adoptive transfer from interferon-alpha-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-alpha secretion
S A Brod, M Khan, L D Nelson, et al.
Annals of Neurology
|
June 1, 1991
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig
S A Brod, A al-Sabbagh, R A Sobel, et al.
Neurology
|
June 1, 1996
Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis
S A Brod, G D Marshall, E M Henninger, et al.
Annals of Neurology
|
January 1, 1991
Common T-cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis
S J Lee, K W Wucherpfennig, S A Brod, et al.
Neurology
|
September 12, 2001
Ingested IFN-alpha: results of a pilot study in relapsing-remitting MS
S A Brod, J W Lindsey, F S Vriesendorp, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Diabetologia
|
October 30, 1998
Ingested interferon alpha suppresses type I diabetes in non-obese diabetic mice
S A Brod, M Malone, S Darcan, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
February 1, 1995
Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons
S A Brod, M Scott, D K Burns, et al.
The International Journal of Neuroscience
|
June 1, 1997
IFN-beta 1b treatment of relapsing multiple sclerosis has no effect on CD3-induced inflammatory or counterregulatory anti-inflammatory cytokine secretion ex vivo after nine months
S A Brod, L D Nelson, M Khan, et al.
Journal of the Neurological Sciences
|
March 13, 2012
Variable results after rituximab in neuromyelitis optica
J W Lindsey, K M Meulmester, S A Brod, et al.
Autoimmunity
|
January 1, 1996
Oral administration of type I interferon modulates the course of experimental allergic neuritis
F J Vriesendorp, R E Flynn, M Khan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 4, 2000
Adoptive transfer from interferon-alpha-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-alpha secretion
S A Brod, M Khan, L D Nelson, et al.
Annals of Neurology
|
June 1, 1991
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig
S A Brod, A al-Sabbagh, R A Sobel, et al.
Neurology
|
June 1, 1996
Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis
S A Brod, G D Marshall, E M Henninger, et al.
Annals of Neurology
|
January 1, 1991
Common T-cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis
S J Lee, K W Wucherpfennig, S A Brod, et al.
Neurology
|
September 12, 2001
Ingested IFN-alpha: results of a pilot study in relapsing-remitting MS
S A Brod, J W Lindsey, F S Vriesendorp, et al.
Page
of 4